Figure 3From: Osteoblast inhibition by chemokine cytokine ligand3 in myeloma-induced bone diseaseCCR1 expression is assessed using flow cytometry. The OB is marked as CD45−CD34−CD138−(A), which both express CCR1 in (B) the patients with MBD and (C) normal controls. (D) The CCR1 level is significantly higher in patients with MBD (74.48 ± 7.31) % than in the normal controls (48.35 ± 8.81) % (P <0.05).Back to article page